Sellas Life Sciences Group (SLS)'s 30-day implied volatility (IV30) was 114.7% at the close on November 5, 2026, down from 156.9% the day before, against a 52-week range of 66.7% to 213.3%. Its 20-day historical volatility was 112.1%.
Data as of November 5, 2026.